Table 2.
Exposure of study participants to medications with anticholinergic and sedating effects
| Drug group | Number exposed (%) |
|---|---|
| Anticholinergics | |
| Antiemetics | 7 (0.4) |
| Antipsychotics | 10 (0.6) |
| Antihistamines | 22 (1.3) |
| Spasmolytics | 26 (1.5) |
| Cardiovascular | 32 (1.9) |
| Parasympathomimetics | 85 (5.0) |
| Antidepressants other than SSRIs | 90 (5.3) |
| Sympathomimetics | 90 (5.3) |
| Sedatives | |
| Dopaminergics | 32 (1.9) |
| Anticonvulsants | 36 (2.1) |
| Opioids | 39 (2.3) |
| Antidepressants-SSRIs | 43 (2.5) |
| Anxiolytics | 77 (4.5) |
n represents the number of study participants taking at least one of the anticholinergic and/or sedative medications. SSRIs, selective serotonin reuptake inhibitors.